MARKET

ICUI

ICUI

ICU Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

177.70
-0.03
-0.02%
After Hours: 177.50 -0.2 -0.11% 16:11 08/07 EDT
OPEN
177.37
PREV CLOSE
177.73
HIGH
179.25
LOW
176.54
VOLUME
101.21K
TURNOVER
--
52 WEEK HIGH
246.12
52 WEEK LOW
148.89
MARKET CAP
3.70B
P/E (TTM)
43.99
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ICUI stock price target is 222.33 with a high estimate of 240.00 and a low estimate of 199.00.

EPS

ICUI News

More
Medical Products Stock Earnings on Aug 10: CGC, SDGR & More
Zacks · 13h ago
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 4d ago
Did Hedge Funds Make The Right Call On ICU Medical, Inc. (ICUI) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds
Insider Monkey · 07/20 16:14
ICU Medical, Inc. Announces Time of Second Quarter 2020 Earnings Conference Call
SAN CLEMENTE, Calif., July 15, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
GlobeNewswire · 07/15 11:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
GlobeNewswire · 06/16 21:18
Is ICU Medical, Inc. (ICUI) Going to Burn These Hedge Funds?
Insider Monkey · 06/15 14:31
ICU Medical Investors: Company Investigated by the Portnoy Law Firm, CEO sold $3.06 million of shares, according to a filing with the U.S. Securities & Exchange Commission
The Portnoy Law Firm advises ICU Medical, Inc. (ICUI) investors that the firm has initiated an investigation into alleged violations of securities laws, and may file a lawsuit on behalf of investors. Investors are encouraged to contact attorney Lesley F. Port
GlobeNewswire · 06/10 17:21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
GlobeNewswire · 06/08 22:56

Industry

Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.49%

Hot Stocks

Symbol
Price
%Change

About ICUI

ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.
More

Webull offers kinds of ICU Medical Inc stock information, including NASDAQ:ICUI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICUI stock methods without spending real money on the virtual paper trading platform.